Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Condition: Pulmonary Sarcoidosis Interventions: Drug: Efzofitimod 3 mg/kg; Drug: Efzofitimod 5 mg/kg; Drug: Placebo Sponsors: aTyr Pharma, Inc.; Kyorin Pharmaceutical Co.,Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials